Developing Consilience Medicine: Positron Emission Tomography Scan and Transcriptomics in Pancreatic Cancer

참고문헌 (8)

1. Sung Hwan Lee, "Preoperative Metabolic Tumor Volume2.5 Associated with Early Systemic Metastasis in Resected Pancreatic Cancer: A Transcriptome-Wide Analysis", Gut and Liver, 13(3), pp.356~365 (2019), 거트앤리버 소화기연관학회협의회[DOI]
2. Wang Z, "FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma : a metaanalysis", World J Gastroenterol, 19, pp.4808~4817 (2013)
3. Jha P, "PET", CT for pancreatic malignancy : potential and pitfalls, 2015, pp.43, 92~97
4. Castelli J, "Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy", Crit Rev Oncol Hematol, 108, pp.40~51 (2016)
5. Kang CM, "Preoperative volume-based PET parameter, MTV2.5, as a potential surrogate marker for tumor biology and recurrence in resected pancreatic cancer", Medicine (Baltimore), 95, pp.e2595~ (2016)
6. Ma W, "Quantitative(18)F-FDG PET analysis in survival rate prediction of patients with non-small cell lung cancer", Oncol Lett, 16, pp.4129~4136 (2018)
7. Lowe R, "Transcriptomics technologies", PLoS Comput Biol, 13, pp.e1005457~ (2017)
8. Hoskins JW, "Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A", Carcinogenesis, 35, pp.2670~2678 (2014)

관련 논문AI추천